Phase II Study of Gamma Interferon (IFN-γ) Added to Bolus + Infusional 5-Fluorouracil (5-FU) and Leucovorin (LV) +/- Bevacizumab (BV) in Metastatic Colorectal Carcinoma.

Trial Profile

Phase II Study of Gamma Interferon (IFN-γ) Added to Bolus + Infusional 5-Fluorouracil (5-FU) and Leucovorin (LV) +/- Bevacizumab (BV) in Metastatic Colorectal Carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Dec 2014

At a glance

  • Drugs Interferon gamma-1b (Primary) ; Bevacizumab; Fluorouracil; Folinic acid
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Feb 2012 Actual patient number change from 70 to 48 as reported by ClinicalTrials.gov.
    • 21 Feb 2012 Actual initiation date change from Apr 2003 to Feb 2006 as reported by ClinicalTrials.gov.
    • 21 Feb 2012 Trial phase change from I/II to II as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top